SCHEMBL694875

SCHEMBL694875

Cc1ccc(-c2cc3c[c]ccc3[nH]2)nc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCR1 P32246 1/20 0.43
CCR5 P51681 1/20 0.43
CCR8 P51685 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
METAP2 P50579 1/20 0.37
AURKA O14965 1/20 0.36
AURKB Q96GD4 1/20 0.36
ITK Q08881 7/20 0.34
POLB P06746 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2A6 P11509 1/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
MAPT P10636 2/20 0.33
HPGD P15428 2/20 0.33
KMT2A Q03164 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL694442 0.82 MAPT (0.37) AURKAAURKBITKMAPTGSK3B
SCHEMBL694773 0.82 KDM4E (0.36) AURKAAURKBNPC1RAB9ASMN1; SMN2
SCHEMBL695340 0.80 AURKA (0.56) CCR1CCR5CCR8HDAC6AURKA
SCHEMBL695324 0.79 CCR1 (0.46) CCR1CCR5CCR8METAP2AURKA
SCHEMBL695181 0.79 NPSR1 (0.37) METAP2KDM4EDYRK1A
SCHEMBL695289 0.77 GSK3B (0.44) AURKAAURKBITKPOLBNPC1
SCHEMBL694241 0.76 LMNA (0.49) CCR1CCR5CCR8METAP2AURKA
SCHEMBL694550 0.75 HPGDS (0.44) NPC1RAB9ASMN1; SMN2KDM4EMEN1
SCHEMBL695383 0.75 CCR1 (0.44) CCR1CCR8METAP2AURKAAURKB
SCHEMBL4278217 0.75 METAP2 (0.40) METAP2GSK3BCLK2CLK3DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP claimed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO claimed
EP-3197450-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2017-08-02 EP disclosed
WO-2016046130-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF FIBROSIS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2016-03-31 WO disclosed
EP-2421825-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS Janssen Pharmaceutica N.V. (BE) 2012-02-29 EP disclosed
WO-2010124108-A1 AZETIDINYL DIAMIDES AS MONOACYLGLYCEROL LIPASE INHIBITORS JANSSEN PHARMACEUTICA NV (BE) 2010-10-28 WO disclosed